Telehealth Cognitive Behavioral Therapy for youth at risk for psychosis
Telehealth Adaptation of Group and Family-Based Cognitive Behavioral Therapy for Youth at Risk for Psychosis
NA · Icahn School of Medicine at Mount Sinai · NCT05968560
This study is testing if online therapy can help young people aged 14-25 who are at risk for psychosis feel better and stay connected with their treatment.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 72 (estimated) |
| Ages | 14 Years to 25 Years |
| Sex | All |
| Sponsor | Icahn School of Medicine at Mount Sinai (other) |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05968560 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility and effectiveness of telehealth interventions for individuals aged 14-25 who are at clinical high risk for psychosis. It focuses on delivering Group and Family-Based Cognitive Behavioral Therapy (CBT) and individual CBT through telehealth to improve accessibility and engagement in treatment. Participants will be randomly assigned to one of the adapted CBT interventions, and the study will measure recruitment rates, attendance, and retention, as well as the impact on cognitive biases and social connectedness. The goal is to reduce barriers to accessing care and improve clinical outcomes for youth at risk.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 14-25 who meet the criteria for psychosis-risk and have a supportive family member willing to participate.
Not a fit: Patients with intellectual disabilities, severe substance use disorders, or medical conditions known to cause psychosis may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance treatment accessibility and engagement for youth at risk of developing psychosis.
How similar studies have performed: Other studies have shown promise in using telehealth for mental health interventions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria:
* Age 14-25
* Ability to participate in assessments and treatment in English
* Meets criteria for psychosis-risk on SIPS
* Stable on medications; no changes within 1 month prior to enrollment
* Identification of one "family member" with \>4 hours/week contact who is willing to participate ("Family member" can be any blood relative, spouse, significant other, or close friend whom the subject identifies as a consistent and important person in their life).
Exclusion criteria:
* Intellectual disability (IQ\<70)
* Medical condition known to cause psychosis
* Moderate or severe substance use disorder and active use within the past 30 days.
Where this trial is running
New York, New York
- Icahn School of Medicine at Mount Sinai — New York, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Yulia Landa — Icahn School of Medicine at Mount Sinai
- Study coordinator: Yulia Landa, PsyD, MS
- Email: yulia.landa@mssm.edu
- Phone: 212-585-4658
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Clinical High Risk for Psychosis